v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
CURRENT ASSETS:    
Cash $ 333,931 $ 2,856,309
Rent receivable 87,317 80,829
Receivable from sale of equity method investment 1,028,500
Prepaid expense and other current assets 639,285 299,360
Total Current Assets 2,089,033 3,236,498
NON-CURRENT ASSETS:    
Operating lease right-of-use assets, net 83,490 4,709
Property and equipment, net 6,355 12,912
Investment in real estate, net 6,932,074 7,022,721
Equity method investments, net 10,636,544
Other non-current assets 17,503 71,794
Total Non-current Assets 7,039,422 17,748,680
Total Assets 9,128,455 20,985,178
CURRENT LIABILITIES:    
Accrued professional fees 1,320,286 611,462
Accrued research and development fees 153,772 153,772
Accrued payroll liability and compensation 827,524 501,258
Accrued litigation settlement 363,450 373,450
Accrued liabilities and other payables 201,067 434,117
Operating lease obligation, current portion 71,691 10,709
Advance from pending sale of noncontrolling interest - related party 3,158,078 3,108,106
Derivative liability 100,423 127,545
Stock subscription liability 150,000
Note payable, net 5,797,466 5,715,447
Convertible note payable, net 1,359,918 2,113,773
Total Current Liabilities 13,603,675 13,882,555
NON-CURRENT LIABILITIES:    
Operating lease obligation, noncurrent portion 17,799  
Total Non-current Liabilities 17,799
Total Liabilities 13,621,474 13,882,555
Commitments and Contingencies (Note 15)
(DEFICIT) EQUITY:    
Preferred stock, Value
Common stock, $0.0001 par value; 100,000,000 shares authorized; 4,100,576 shares issued and 4,097,109 shares outstanding at September 30, 2025; 1,445,979 shares issued and 1,442,512 shares outstanding at December 31, 2024 410 145
Additional paid-in capital 87,494,414 72,023,525
Less: common stock held in treasury, at cost; 3,467 shares at September 30, 2025 and December 31, 2024 (522,500) (522,500)
Accumulated deficit (103,868,102) (87,673,125)
Statutory reserve 6,578 6,578
Accumulated other comprehensive loss (231,346) (232,000)
Total Avalon GloboCare Corp. stockholders’ (deficit) equity (4,493,019) 7,102,623
Noncontrolling interest
Total (Deficit) Equity (4,493,019) 7,102,623
Total Liabilities and (Deficit) Equity 9,128,455 20,985,178
Series A Convertible Preferred Stock    
(DEFICIT) EQUITY:    
Preferred stock, Value 9,000,000
Series B Convertible Preferred Stock    
(DEFICIT) EQUITY:    
Preferred stock, Value 11,000,000
Series C Convertible Preferred Stock    
(DEFICIT) EQUITY:    
Preferred stock, Value 3,790,000 3,500,000
Series D Convertible Preferred Stock    
(DEFICIT) EQUITY:    
Preferred stock, Value 8,837,527
Related Party    
CURRENT LIABILITIES:    
Accrued liabilities and other payables - related parties $ 100,000 $ 732,916

Source

PDF HTML
ZIP